BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27687692)

  • 41. Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP.
    Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Hematology; 2017 Oct; 22(9):521-526. PubMed ID: 28413914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.
    Ayoub Z; Andraos T; Milgrom SA; Pinnix CC; Dabaja BS; Ng SP; Gunther JR; Khoury JD; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Nastoupil LJ
    Leuk Lymphoma; 2019 Oct; 60(10):2432-2440. PubMed ID: 30942648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low grade follicular lymphoma with high proliferation index; diagnostic and management issues.
    Das S; Basu D; Dubashi B; Jain A
    Indian J Pathol Microbiol; 2012; 55(4):516-8. PubMed ID: 23455792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.
    Mihaljevic B; Jelicic J; Andjelic B; Antic D; Markovic O; Petkovic I; Jovanovic MP; Trajkovic G; Bila J; Djurasinovic V; Sretenovic A; Vukovic V; Smiljanic M; Balint MT
    Int J Hematol; 2016 Dec; 104(6):692-699. PubMed ID: 27714586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma.
    Krishnadasan R; Bifulco C; Kim J; Rodov S; Zieske AW; Vanasse GJ
    Br J Haematol; 2006 Oct; 135(1):72-5. PubMed ID: 16939500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of clinical features and prognostic factors in 59 cases of follicular lymphoma].
    Zhang W; Wang J; Wan W; Wan WL; Wang JJ; Hu K; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1448-53. PubMed ID: 24370027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary cutaneous follicle center cell lymphoma and limited stage follicular non-Hodgkin's lymphoma: a comparison of clinical and biological features.
    Anghel G; Pulsoni A; De Rosa L
    Leuk Lymphoma; 2002 Nov; 43(11):2109-15. PubMed ID: 12533035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follicular T-cell lymphoma.
    Lisa M; Verma PK; Nishi ; Shuchismita ; Hussain MA
    J Cancer Res Ther; 2021; 17(6):1568-1571. PubMed ID: 34916399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
    Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
    Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
    Novelli S; Briones J; Flotats A; Sierra J
    Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
    Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
    Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
    Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
    Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
    Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers CR; Zelenetz AD; Dawson KL; Reid E
    Leuk Lymphoma; 2017 Apr; 58(4):809-815. PubMed ID: 27562750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.
    Xerri L; Bachy E; Fabiani B; Canioni D; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Brousse N; Rousselet MC; Foussard C; Brice P; Feugier P; Morschhauser F; Sonet A; Olive D; Salles G;
    Hum Pathol; 2014 Oct; 45(10):2085-93. PubMed ID: 25149549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
    Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mass Cytometry Analysis Reveals that Specific Intratumoral CD4
    Yang ZZ; Kim HJ; Villasboas JC; Price-Troska T; Jalali S; Wu H; Luchtel RA; Polley MC; Novak AJ; Ansell SM
    Cell Rep; 2019 Feb; 26(8):2178-2193.e3. PubMed ID: 30784598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.
    Dargent JL; Lespagnard L; Meiers I; Bradstreet C; Heimann P; De Wolf-Peeters C
    Virchows Arch; 2005 Oct; 447(4):778-80. PubMed ID: 15983819
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
    Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
    Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current clinical aspects of follicular lymphoma].
    Dreyling M
    Ther Umsch; 2010 Oct; 67(10):511-6. PubMed ID: 20886457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.